Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia

Wolff Kirsch1, Grant McAuley, Barbara Holshouser

  • 1Neurosurgery Center for Research, Training, and Education, Loma Linda University, 11175 Campus Street, Suite 11113, Loma Linda, CA 92350, USA. wkirsch@llu.edu

Insights

Susceptibility weighted imaging (SWI) can quantify brain iron and microbleeds. Increased iron in the putamen and the presence of microbleeds are linked to dementia progression in individuals with mild cognitive impairment.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarkers

Background:

  • Alzheimer's disease and related dementias are a growing public health concern.
  • Accurate biomarkers for early detection and monitoring of neurodegenerative diseases are crucial.
  • Assessing regional brain iron levels and microbleeds may offer insights into disease mechanisms.

Purpose of the Study:

  • To evaluate the utility of susceptibility weighted imaging (SWI) for serial quantitation of regional brain iron and detection of brain microbleeds (BMB).
  • To investigate the association of iron levels and BMB with cognitive decline and dementia progression in elderly individuals.

Main Methods:

  • Serial acquisition of SWI in cohorts of mildly cognitively impaired (MCI) and cognitively normal participants over up to 50 months.
  • Quantification of SWI phase values (putative iron levels) in 14 brain regions.
  • Counting of BMB for each SWI study.

Main Results:

  • A significant increase in left putaminal iron (decrease in SWI phase values) was observed in participants who progressed to dementia compared to controls (p = 0.035) and stable MCI (p = 0.01).
  • Brain microbleeds (BMB) were detected in 38% of MCI participants who progressed to dementia.
  • BMB were identified as a significant risk factor for cognitive failure in MCI participants (risk ratio = 2.06).

Conclusions:

  • SWI is a valuable tool for measuring regional iron changes and detecting BMB in the brain.
  • Iron accumulation and BMB may serve as important MR-based biomarkers for neurodegenerative diseases.
  • These findings support the potential of SWI in the early detection and monitoring of dementia.